Alphamab Oncology (FRA:3NK)
Germany · Delayed Price · Currency is EUR 1.060
+0.010 (0.95%)
Last updated: Jan 6, 2026, 9:10 AM CET
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of €1.17 billion as of January 9, 2026. Its market cap has increased by 190.60% in one year.
Market Cap
1.17B
Enterprise Value
1.00B
Revenue
93.42M
Ranking
n/a
PE Ratio
42.19
Stock Price
€1.06
Market Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 1.40B to 1.17B, a decrease of -16.32%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.17B | 12.41% |
| Dec 31, 2025 | 1.04B | 147.98% |
| Dec 31, 2024 | 418.85M | -43.55% |
| Dec 29, 2023 | 741.95M | -39.08% |
| Dec 30, 2022 | 1.22B | -15.24% |
| Dec 31, 2021 | 1.44B | -10.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |